Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) meeting in Copenhagen this week is celebrating its 40th edition. In recognition of this landmark, the ...

Roivant Sciences Ltd. has sold another company, this time offering up Dermavant Sciences Ltd. to Organon & Co. for $1.2 billion. The deal brings Organon into a crowded market for plaque psoriasis ...

Australia’s Health Department has released the final report of the Health Technology Assessment (HTA) Review that makes 50 ...

How do exercise and insulin collaborate in metabolism? The European Association for the Study of Diabetes (EASD) and the Novo ...

Strategics tend to invest in med-tech companies they are looking to acquire or could be acquired. Furthermore, companies like ...

Epitomee Ltd. happily swallowed the news of U.S. FDA clearance for its capsule for weight management, an ingestible medical device for adults who are overweight or obese. Designed for use along with ...

The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a ...

Scattered investor qualms about Nuvalent Inc.’s largely upbeat data during the European Society for Medical Oncology (ESMO) ...

Nuvalent Inc. followed positive data during the European Society for Medical Oncology (ESMO) meeting with an upsized $500 million public offering. The Cambridge, Mass.-based firm is selling 5 million ...

The map of the human brain is not a static image of the cellular architecture of the central nervous system (CNS). Throughout ...

The U.S. FDA reported Sept. 17 that the Zimmer Biomet Holdings Inc. CPT hip system is associated with an increased risk of ...

There has been growing interest in developing novel cannabinoid CB1 receptor inverse agonists to treat obesity and its ...